# Loss of DIAPH3 accelerates glioma genesis in mice

**Authors:** Georges Chehade, Irene Durá, Nuria Ruiz-Reig, Devid Damiani, Eva On-Chai Lau, Julie Lelotte, Nicolas Joudiou, Mohamed Aittaleb, Fadel Tissir

PMC · DOI: 10.1038/s41419-026-08652-x · Cell Death & Disease · 2026-03-23

## TL;DR

Removing DIAPH3 in mice speeds up the development of brain tumors by causing genetic instability and resistance to radiation.

## Contribution

This study reveals DIAPH3 as a tumor suppressor in glioma development through its role in genome stability and radiation resistance.

## Key findings

- Loss of DIAPH3 and TRP53 leads to earlier tumor formation and increased DNA damage in mice.
- DIAPH3 deficiency causes aneuploidy and genome instability, accelerating glioma progression.
- Glioma stem-like cells lacking DIAPH3 show resistance to ionizing radiation.

## Abstract

DIAPH3 is a master regulator of the cytoskeleton with key roles in cell division. In the mouse brain, DIAPH3-deficient neural stem cells exhibit abnormalities in karyokinesis and cytokinesis, leading to cell cycle arrest, aneuploidy, and mitotic catastrophe. Here, we investigated the role of DIAPH3 in glioma genesis in mouse models. We selectively deleted the Diaph3 and Trp53 genes in the mouse cerebral cortex and thoroughly analyzed single (Diaph3 cKO and Trp53 cKO) and double (dcKO) conditional knockout mice. The tumors appeared earlier in dcKO than in Trp53 cKO mice, and this was associated with increased whole chromosome copy number alterations, endogenous DNA damage, and shorter survival of dcKO mice. We performed a comparative transcriptomic analysis prior to the onset of tumors and identified changes in cancer gene signatures specifically in dcKO, suggesting that the loss of DIAPH3 hastens the tumorigenic process. We isolated cancer stem-like cells and assessed their sensitivity to ionizing radiation and found that DIAPH3 regulates the resistance of glioma stem-like cells to irradiation. Our data suggest that DIAPH3 has a tumor-suppressor function and that its deficiency promotes aneuploidy and genome instability, accelerating tumorigenesis and leading to early onset of high-grade diffuse glioma with DNA damage, and resistance to ionizing radiation.

## Linked entities

- **Genes:** DIAPH3 (diaphanous related formin 3) [NCBI Gene 81624], TP53 (tumor protein p53) [NCBI Gene 7157]
- **Diseases:** glioma (MONDO:0021042)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Dnase1 (deoxyribonuclease I) [NCBI Gene 13419] {aka DNaseI, Dnl1}, H2ax (H2A.X variant histone) [NCBI Gene 15270] {aka H2A.X, H2afx, Hist5-2ax, gammaH2ax}, Chek2 (checkpoint kinase 2) [NCBI Gene 50883] {aka CHK2, Cds1, HUCDS1, Rad53}, Rap1a (Rap1a member of RAS oncogene family) [NCBI Gene 109905] {aka G-22K, Krev-1, Rap1}, TPBG (trophoblast glycoprotein) [NCBI Gene 7162] {aka 5T4, 5T4AG, M6P1, WAIF1}, Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], Atm (ataxia telangiectasia mutated) [NCBI Gene 11920] {aka C030026E19Rik}, MGMT (O-6-methylguanine-DNA methyltransferase) [NCBI Gene 4255], Egf (epidermal growth factor) [NCBI Gene 13645], TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Brca1 (breast cancer 1, early onset) [NCBI Gene 12189], Gpr34 (G protein-coupled receptor 34) [NCBI Gene 23890] {aka Lypsr1}, Egfr (epidermal growth factor receptor) [NCBI Gene 13649] {aka 9030024J15Rik, Erbb, Errb1, Errp, Wa5, wa-2}, Pten (phosphatase and tensin homolog) [NCBI Gene 19211] {aka 2310035O07Rik, A130070J02Rik, B430203M17Rik, MMAC1, PTENbeta, TEP1}, FMNL1 (formin like 1) [NCBI Gene 752] {aka C17orf1, C17orf1B, FHOD4, FMNL, KW-13}, MUC3A (mucin 3A, cell surface associated) [NCBI Gene 4584] {aka MUC-3A, MUC3}, Emx1 (empty spiracles homeobox 1) [NCBI Gene 13796], DIAPH3 (diaphanous related formin 3) [NCBI Gene 81624] {aka AN, AUNA1, DIA2, DRF3, NSDAN, diap3}, Diaph3 (diaphanous related formin 3) [NCBI Gene 56419] {aka 4930417P13Rik, Dia2, Diap3, Drf3, p134MDia2}, FGFR2 (fibroblast growth factor receptor 2) [NCBI Gene 2263] {aka BBDS, BEK, BFR-1, CD332, CEK3, CFD1}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Trp53 (transformation related protein 53) [NCBI Gene 22059] {aka Tp53, bbl, bfy, bhy, p44, p53}, TOX4 (TOX high mobility group box family member 4) [NCBI Gene 9878] {aka C14orf92, KIAA0737, LCP1, MIG7}, KIF2C (kinesin family member 2C) [NCBI Gene 11004] {aka CT139, KNSL6, MCAK}, Olig2 (oligodendrocyte transcription factor 2) [NCBI Gene 50913] {aka Bhlhb1, Olg-2, Oligo2, RK17, bHLHe19}, Fgfr2 (fibroblast growth factor receptor 2) [NCBI Gene 14183] {aka Bek, Fgfr-2, Fgfr-7, Fgfr2b, Fgfr7, KGFR}, Rad51 (RAD51 recombinase) [NCBI Gene 19361] {aka Rad51a, Reca}
- **Diseases:** hematological toxicity (MESH:D006402), colorectal cancer (MESH:D015179), CIN (MESH:D043171), Aneuploidy (MESH:D000782), colorectal, ovarian, and gastric cancers (MESH:D013276), tumorigenic (MESH:D002471), OB (MESH:D000857), clear cell renal cell carcinoma (MESH:D002292), necrosis (MESH:D009336), Brain tumor (MESH:D001932), non-small cell lung cancer (MESH:D002289), cytotoxic (MESH:D064420), diffuse (MESH:D008228), Cancer (MESH:D009369), lethargy (MESH:D053609), aggressiveness (MESH:D010554), tumorigenesis (MESH:D063646), metastasis (MESH:D009362), GBM (MESH:D005909), Glioma (MESH:D005910)
- **Chemicals:** cyclic nucleotide (MESH:D009712), HEPES (MESH:D006531), amphotericin B (MESH:D000666), hematoxylin (MESH:D006416), sucrose (MESH:D013395), GlutaMAX (MESH:C054122), paraformaldehyde (MESH:C003043), DAPI (MESH:C007293), eosin (MESH:D004801), vitamin A (MESH:D014801), temozolomide (MESH:D000077204), PBS (MESH:D007854), penicillin (MESH:D010406), endocannabinoid (MESH:D063388), isoflurane (MESH:D007530), DMEM/F-12 (-), reactive oxygen species (MESH:D017382), H (MESH:D006859), streptomycin (MESH:D013307)
- **Species:** Homo sapiens (human, species) [taxon 9606], Danio rerio (leopard danio, species) [taxon 7955], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** l37Cs — Homo sapiens (Human), Chondrosarcoma, Cancer cell line (CVCL_T023), IBL 637 — Homo sapiens (Human), AIDS-related immunoblastic lymphoma, Cancer cell line (CVCL_9638), U251 — Homo sapiens (Human), Astrocytoma, Cancer cell line (CVCL_0021)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13040077/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13040077/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC13040077/full.md

---
Source: https://tomesphere.com/paper/PMC13040077